Skip to main content
Have a personal or library account? Click to login
Hypercoagulability and the A1298C MTHFR Mutation: Case Series of Unexplained Pulmonary Embolism Cover

Hypercoagulability and the A1298C MTHFR Mutation: Case Series of Unexplained Pulmonary Embolism

Open Access
|May 2025

Abstract

Methylenetetrahydrofolate reductase gene (MTHFR) mutations can lead to hyperhomocysteinemia, a known risk factor for venous thromboembolism. In some studies, the A1298C and C677T polymorphisms of the MTHFR gene have been linked to thrombosis, though their clinical significance remains debated. This case presents a detailed analysis of two premenopausal females who presented with pulmonary embolism and were subsequently diagnosed with the A1298C mutation, indicating a potential relation between the A1298C mutation of the MTHFR gene and the subsequent triggering events of thrombotic manifestations associated with raised levels of homocysteine. The varying clinical presentations and biochemical profiles underscore the complex relationship between genotype and phenotype in MTHFR-associated thrombophilias.

DOI: https://doi.org/10.14797/mdcvj.1565 | Journal eISSN: 1947-6108
Language: English
Page range: 57 - 62
Submitted on: Jan 11, 2025
Accepted on: Mar 27, 2025
Published on: May 30, 2025
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services

© 2025 Akshat Sahai, Vaibhav Sharma, Prapti Mishra, Avinash Siddanoor, Abhishek Bhatia, Deepak Gargi Pande, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.